ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen (DAS181-2-05)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01644877
Recruitment Status : Completed
First Posted : July 19, 2012
Last Update Posted : September 25, 2017
Sponsor:
Information provided by (Responsible Party):
Ansun Biopharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 15, 2016
  Actual Study Completion Date : December 15, 2016